The most frequent adverse events ( AEs ) in the telaprevir phase were fatigue ( @ % ) , pruritus ( @ % ) , anemia ( @ % ) , nausea ( @ % ) , rash ( @ % ) , and headache ( @ % ) ; serious AEs were reported in @ % of patients .